News

MicroPhage has launched its multi-site clinical trial to support a FDA premarket notification 510(k). The platform has been developed to rapidly identify bacterial infections and determine antibiotic susceptibility

Bristol-Myers Squibb has extended its previously announced cash tender offer, through its wholly-owned subsidiary Puma Acquisition Corporation (Puma), to purchase all outstanding shares of common stock of Medarex

INVISTA has signed a technology licensing agreement with Chongqing Jian-Feng Industrial Group, to license its BDO and PTMEG manufacturing technologies to the Chinese company. Jian-Feng is investing RMB2

ZymoGenetics has reported the submission of a Citizen Petition to the FDA, requesting the removal of Thrombin-JMI Thrombin, topical (bovine origin) from the market, in the interest of

Law Offices of Howard G Smith, representing investors of Align Technology (Align) has filed a class action lawsuit in US District Court for the Northern District of California

TTY Biopharm has signed an agreement with to-BBB for the manufacturing of brain-targeted doxorubicin liposomes. These liposomes are essential for the clinical development of to-BBB’s lead product for

inPharmative has completed the implementation of its pharmaceutical rebate management technology solution for Blue Cross Blue Shield of Arizona. inPharmative provides rebate management technology solutions through web-based decision

Pfizer has collaborated with Private Access to create a new online community aimed at increasing clinical trial awareness and participation. The site will focus on patient privacy rights

International Oncology Network (ION) has entered into an agreement with Altos Solutions that gives access to OncoEMR, Altos Solutions’ electronic medical records (EMR) system. The company claims that